Sponsored

  • Dr. Promilla Butani: Baby Vaccination Clinic In South Delhi

    Dr. Promilla Butani's Pediatrics Practice led by Dr. Promilla Butani, is a leading baby vaccination clinic in South Delhi. It is a parent-friendly clinic that caters to the needs of newborns, adolescents, and children. The clinic offers a range of vaccinations for children between the ages of 0-5 and 5, as well as for adults and elderly people. Some of the common vaccinations offered at the clinic include Hepatitis A Vaccine, flu vaccine, pneumococcal vaccine, tetanus, rotavirus vaccine, measles, typhoid conjugate vaccine, HPV, and many more. To avail the benefits of these vaccines.
    Website: https://www.drpromillabutani.com/immunization-and-vaccination-services.php
    Dr. Promilla Butani: Baby Vaccination Clinic In South Delhi Dr. Promilla Butani's Pediatrics Practice led by Dr. Promilla Butani, is a leading baby vaccination clinic in South Delhi. It is a parent-friendly clinic that caters to the needs of newborns, adolescents, and children. The clinic offers a range of vaccinations for children between the ages of 0-5 and 5, as well as for adults and elderly people. Some of the common vaccinations offered at the clinic include Hepatitis A Vaccine, flu vaccine, pneumococcal vaccine, tetanus, rotavirus vaccine, measles, typhoid conjugate vaccine, HPV, and many more. To avail the benefits of these vaccines. Website: https://www.drpromillabutani.com/immunization-and-vaccination-services.php
    0 Comments 0 Shares
  • Opportunities in RNA Therapeutics market Growth Opportunity and Industry Forecast to 2035

    The phenomenal success of RNA-based products in tackling the COVID-19 pandemic, globally, as well as their potential to actualize the concept of personalized medicine has resulted in a significant growth in the investment activity in this sector.

    Roots Analysis is pleased to announce the publication of its recent study, titled, “Investor Series: Opportunities in the RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)”.

    The report provides detailed information on the RNA therapeutics market, covering various RNA therapies, including RNAi therapies, RNA aptamers, and mRNA therapies and vaccines. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of future business success, over the coming decade. The information in this report has been presented across multiple deliverables, featuring MS Excel sheets (some of which include interactive elements) and a MS PowerPoint deck, which summarizes the key takeaways from the project and insights drawn from the curated data. Amongst other elements, the report includes:
     An introduction to RNA therapeutics, highlighting prominent barriers to the development and success of RNA therapies.
     A detailed analysis of RNA therapeutics focused companies that were established post-2006.
     An assessment of the various products, offered by the key innovator companies.

     A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry, namely operations-related risks, business-related risks, financial / asset-related risks, product / technology-related risks, and social, economic, environmental and political risks..
     A case study where RNA therapeutics investors have exited various RNA therapeutics-related ventures, offering insights on returns on investment received.
     A key acquisition targets analysis, based on the insights generated during the course of this study.
     A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
     Type of Therapy
     mRNA Vaccines and Therapeutics
     RNAi Therapeutics
     RNA Aptamers

     Therapeutic Area
     Infectious Diseases
     Genetic Disorders
     Haematological Disorders
     Metabolic Disorders
     Ocular Disorders
     Oncological Disorders
     Renal Disorders


    The research also includes detailed profiles of key public ventures engaged in the development of RNA therapeutics; each profile features a brief overview of the company, along with information on its management team, insights from its balance sheet (if available), as well as details related to its product portfolio, recent developments and key financials (including company investment highlights, company fundamental and company technical analysis).
     Arcturus Therapeutics
     Ascletis Pharma
     Avidity Biosciences
     BioNtech
     CanSino Biologics
     Gritstone bio
     IVERIC bio
     Moderna
     Phio Pharmaceuticals
     Vir Biotechnology

    To view more details on this report, click on the link
    https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market.html

    Learn from experts: do you know about these emerging industry trends?
    Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
    4D Bioprinting Market: Key Trends

    About Roots Analysis
    Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

    Learn more about Roots Analysis consulting services:
    Roots Analysis Consulting - the preferred research partner for global firms

    Contact:
    Ben Johnson
    +1 (415) 800 3415
    [email protected]

    #opportunitiesinRNAtherapeuticsmarket #RNAtherapeuticsfunding
    Opportunities in RNA Therapeutics market Growth Opportunity and Industry Forecast to 2035 The phenomenal success of RNA-based products in tackling the COVID-19 pandemic, globally, as well as their potential to actualize the concept of personalized medicine has resulted in a significant growth in the investment activity in this sector. Roots Analysis is pleased to announce the publication of its recent study, titled, “Investor Series: Opportunities in the RNA Therapeutics Market (mRNA Therapeutics and Vaccines, RNAi Therapeutics, and RNA Aptamers)”. The report provides detailed information on the RNA therapeutics market, covering various RNA therapies, including RNAi therapies, RNA aptamers, and mRNA therapies and vaccines. It offers a technical and financial perspective on how the opportunity in this domain is likely to evolve, in terms of future business success, over the coming decade. The information in this report has been presented across multiple deliverables, featuring MS Excel sheets (some of which include interactive elements) and a MS PowerPoint deck, which summarizes the key takeaways from the project and insights drawn from the curated data. Amongst other elements, the report includes:  An introduction to RNA therapeutics, highlighting prominent barriers to the development and success of RNA therapies.  A detailed analysis of RNA therapeutics focused companies that were established post-2006.  An assessment of the various products, offered by the key innovator companies.  A case study on the assessment of business risks, based on some of the major risk categories that are usually discussed in the industry, namely operations-related risks, business-related risks, financial / asset-related risks, product / technology-related risks, and social, economic, environmental and political risks..  A case study where RNA therapeutics investors have exited various RNA therapeutics-related ventures, offering insights on returns on investment received.  A key acquisition targets analysis, based on the insights generated during the course of this study.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Therapy  mRNA Vaccines and Therapeutics  RNAi Therapeutics  RNA Aptamers  Therapeutic Area  Infectious Diseases  Genetic Disorders  Haematological Disorders  Metabolic Disorders  Ocular Disorders  Oncological Disorders  Renal Disorders The research also includes detailed profiles of key public ventures engaged in the development of RNA therapeutics; each profile features a brief overview of the company, along with information on its management team, insights from its balance sheet (if available), as well as details related to its product portfolio, recent developments and key financials (including company investment highlights, company fundamental and company technical analysis).  Arcturus Therapeutics  Ascletis Pharma  Avidity Biosciences  BioNtech  CanSino Biologics  Gritstone bio  IVERIC bio  Moderna  Phio Pharmaceuticals  Vir Biotechnology To view more details on this report, click on the link https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market.html Learn from experts: do you know about these emerging industry trends? Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders 4D Bioprinting Market: Key Trends About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 [email protected] #opportunitiesinRNAtherapeuticsmarket #RNAtherapeuticsfunding
    0 Comments 0 Shares
  • Baby Vaccination in South Delhi by Dr. Promilla Butani

    Vaccines protect one against certain diseases. They also protect the baby from diseases and prevent diseases from spreading to others. Dr. Promilla Butani, a leading pediatrician, offers the best baby vaccination in South Delhi. Vaccinations help protect the baby from certain diseases such as flu, Hepatitis A and B, measles, mumps, rubella, and many more. The common vaccinations offered at Dr. Promilla Butani's Pediatrics Practice include OPV/IPV Rotavirus, BCG, HIB, measles, flu vaccines, etc. Visit the clinic to get your child vaccinated. Getting on-time vaccinations will aid your kid in staying disease-free and healthy.

    Website: https://www.drpromillabutani.com/immunization-and-vaccination-services.php
    Baby Vaccination in South Delhi by Dr. Promilla Butani Vaccines protect one against certain diseases. They also protect the baby from diseases and prevent diseases from spreading to others. Dr. Promilla Butani, a leading pediatrician, offers the best baby vaccination in South Delhi. Vaccinations help protect the baby from certain diseases such as flu, Hepatitis A and B, measles, mumps, rubella, and many more. The common vaccinations offered at Dr. Promilla Butani's Pediatrics Practice include OPV/IPV Rotavirus, BCG, HIB, measles, flu vaccines, etc. Visit the clinic to get your child vaccinated. Getting on-time vaccinations will aid your kid in staying disease-free and healthy. Website: https://www.drpromillabutani.com/immunization-and-vaccination-services.php
    0 Comments 0 Shares
  • 6 major trends affecting the future of healthcare supply chains

    #ClaudiaRoa #LifeSciences #HealthcareSectoratDHLCustomerSolutionsandInnovation #biopharmaceuticalproducts #genebasedmedicine #sustainability #automotiveindustry #medicaldevices #consumerhealthcare #clinicaltrials #vaccineshortages #COVID19pandemic #activepharmaceuticalingredients #logisticscompany #DHL #digitalization #healthcare #autologouscelltherapies #supplychains

    6 major trends affecting the future of healthcare supply chains #ClaudiaRoa #LifeSciences #HealthcareSectoratDHLCustomerSolutionsandInnovation #biopharmaceuticalproducts #genebasedmedicine #sustainability #automotiveindustry #medicaldevices #consumerhealthcare #clinicaltrials #vaccineshortages #COVID19pandemic #activepharmaceuticalingredients #logisticscompany #DHL #digitalization #healthcare #autologouscelltherapies #supplychains
    WWW.LOGUPDATEAFRICA.COM
    6 major trends affecting the future of healthcare supply chains
    The rapid transformation of the life sciences and healthcare sector is also driving changes in logistics
    0 Comments 0 Shares
  • Six Must-have Vaccines for Newborn Babies

    Vaccinations are essential to providing the required immunity to babies. One dose can protect them from a life-threatening occurrence. Following the plan in the next few months and years will give your child lifelong immunity to deadly illnesses. Dr. Promilla Butani of Dr. Promilla Butani's Pediatrics Practice, who provides the best baby vaccination in South Delhi, suggests the top 6 vaccinations that babies must get. This gives a brief introduction to all.
    Website: https://www.drpromillabutani.com/immunization-and-vaccination-services.php
    Six Must-have Vaccines for Newborn Babies Vaccinations are essential to providing the required immunity to babies. One dose can protect them from a life-threatening occurrence. Following the plan in the next few months and years will give your child lifelong immunity to deadly illnesses. Dr. Promilla Butani of Dr. Promilla Butani's Pediatrics Practice, who provides the best baby vaccination in South Delhi, suggests the top 6 vaccinations that babies must get. This gives a brief introduction to all. Website: https://www.drpromillabutani.com/immunization-and-vaccination-services.php
    0 Comments 0 Shares
  • Innovations and staff expertise to enhance Cathay Pacific Cargo customer options for life-science shipments

    #CathayPacific #CathayPacificCargo #CathayPharma #UltraTrack #VaccineSolution #HongKongInternationalAirport #pharma
    Innovations and staff expertise to enhance Cathay Pacific Cargo customer options for life-science shipments #CathayPacific #CathayPacificCargo #CathayPharma #UltraTrack #VaccineSolution #HongKongInternationalAirport #pharma
    WWW.STATTIMES.COM
    Cathay Pharma: a refreshed temperature-sensitive solution
    Innovations and staff expertise to enhance Cathay Pacific Cargo customer options for life-science shipments
    0 Comments 0 Shares
  • TechEagle transports vaccine for Arunachal's animal husbandry dept

    TechEagle aims to strengthen transporting vaccines & essential medical deliveries not only for humans but also animals

    https://www.itln.in/cargo-drones/techeagle-transports-vaccine-for-arunachals-animal-husbandry-dept-1347017
    TechEagle transports vaccine for Arunachal's animal husbandry dept TechEagle aims to strengthen transporting vaccines & essential medical deliveries not only for humans but also animals https://www.itln.in/cargo-drones/techeagle-transports-vaccine-for-arunachals-animal-husbandry-dept-1347017
    WWW.ITLN.IN
    TechEagle transports vaccine for Arunachal's animal husbandry dept
    TechEagle aims to strengthen transporting vaccines & essential medical deliveries not only for humans but also animals
    0 Comments 0 Shares
  • TechEagle aims to strengthen transporting vaccines & essential medical deliveries not only for humans but also animals

    #TechEagle #ArunachalPradesh #TageTaki #drones #transports #vaccine #medical
    TechEagle aims to strengthen transporting vaccines & essential medical deliveries not only for humans but also animals #TechEagle #ArunachalPradesh #TageTaki #drones #transports #vaccine #medical
    WWW.STATTIMES.COM
    TechEagle transports vaccine for Arunachal's animal husbandry dept
    TechEagle aims to strengthen transporting vaccines & essential medical deliveries not only for humans but also animals
    0 Comments 0 Shares
  • Gavi, Moderna update agreement for 100mn doses of Covid vaccines

    Gavi and Moderna agree to cancel remaining volumes under their previous agreement in 2022

    https://www.itln.in/pharma/gavi-moderna-update-agreement-for-100mn-doses-of-covid-vaccines-1346762
    Gavi, Moderna update agreement for 100mn doses of Covid vaccines Gavi and Moderna agree to cancel remaining volumes under their previous agreement in 2022 https://www.itln.in/pharma/gavi-moderna-update-agreement-for-100mn-doses-of-covid-vaccines-1346762
    WWW.ITLN.IN
    Gavi, Moderna update agreement for 100mn doses of Covid vaccines
    Gavi and Moderna agree to cancel remaining volumes under their previous agreement in 2022
    0 Comments 0 Shares
  • IBS Software to power IATA's new CASSLink initiative

    #IBSSoftware #SaaSsolutionsprovider #InternationalAirTransportAssociation #IATA #UnitedStates #CargoNetworkServices #customermanagementsystem #CargoAccountsSettlementSystem #paymentinnovations #analytics #pandemic #vaccines #medicalsupplies #IATA #CASSLink #airlines #freightforwarders #aircargoindustry #globalsupplychain #DigitalTransformation

    IBS Software to power IATA's new CASSLink initiative #IBSSoftware #SaaSsolutionsprovider #InternationalAirTransportAssociation #IATA #UnitedStates #CargoNetworkServices #customermanagementsystem #CargoAccountsSettlementSystem #paymentinnovations #analytics #pandemic #vaccines #medicalsupplies #IATA #CASSLink #airlines #freightforwarders #aircargoindustry #globalsupplychain #DigitalTransformation
    WWW.LOGUPDATEAFRICA.COM
    IBS Software to power IATA's new CASSLink initiative
    The CASSLink initiative is aimed at transforming air cargo payments
    0 Comments 0 Shares
More Results
Sponsored

Sponsored


Don't forget, ads time: PentaVerge | AQU | Debwan | ICICTE | Nasseej | ESol | OUST | CorpSNet | PoemsBook | TopDeals | TheReaderView